Barclays Trims Keurig Dr Pepper (NASDAQ:KDP) Target Price to $37.00

Keurig Dr Pepper (NASDAQ:KDP) had its price target reduced by Barclays from $38.00 to $37.00 in a research note issued to investors on Friday, Benzinga reports. Barclays currently has an overweight rating on the stock.

Several other research firms have also weighed in on KDP. Jefferies Financial Group cut their target price on shares of Keurig Dr Pepper from $37.00 to $35.00 and set a buy rating for the company in a report on Wednesday, March 27th. Wells Fargo & Company boosted their price target on shares of Keurig Dr Pepper from $39.00 to $41.00 and gave the stock an overweight rating in a report on Wednesday, June 5th. JPMorgan Chase & Co. cut their price target on shares of Keurig Dr Pepper from $37.00 to $36.00 and set an overweight rating for the company in a report on Wednesday, July 10th. UBS Group boosted their price target on shares of Keurig Dr Pepper from $39.00 to $40.00 and gave the stock a buy rating in a report on Monday, June 10th. Finally, TD Cowen boosted their price target on shares of Keurig Dr Pepper from $32.00 to $35.00 and gave the stock a hold rating in a report on Friday, April 26th. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, Keurig Dr Pepper currently has a consensus rating of Moderate Buy and a consensus target price of $36.50.

Keurig Dr Pepper Stock Performance

Shares of NASDAQ KDP opened at $32.83 on Friday. The company has a current ratio of 0.51, a quick ratio of 0.34 and a debt-to-equity ratio of 0.52. Keurig Dr Pepper has a 12 month low of $27.66 and a 12 month high of $35.00. The company has a 50 day simple moving average of $33.68 and a two-hundred day simple moving average of $32.07. The stock has a market cap of $44.50 billion, a price-to-earnings ratio of 21.18, a PEG ratio of 2.55 and a beta of 0.62.

Keurig Dr Pepper (NASDAQ:KDP) last announced its quarterly earnings data on Thursday, April 25th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.34 by $0.04. Keurig Dr Pepper had a net margin of 14.52% and a return on equity of 10.18%. The business had revenue of $3.47 billion during the quarter, compared to analysts’ expectations of $3.41 billion. During the same period in the previous year, the business posted $0.34 EPS. The business’s quarterly revenue was up 3.4% compared to the same quarter last year. As a group, analysts predict that Keurig Dr Pepper will post 1.92 earnings per share for the current year.

Keurig Dr Pepper Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, July 12th. Stockholders of record on Friday, June 28th were given a dividend of $0.215 per share. The ex-dividend date was Friday, June 28th. This represents a $0.86 annualized dividend and a dividend yield of 2.62%. Keurig Dr Pepper’s payout ratio is 55.48%.

Insider Activity

In other Keurig Dr Pepper news, insider Roger Frederick Johnson sold 31,227 shares of the company’s stock in a transaction dated Friday, April 26th. The shares were sold at an average price of $33.82, for a total value of $1,056,097.14. Following the transaction, the insider now owns 100,000 shares of the company’s stock, valued at $3,382,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Keurig Dr Pepper news, insider Roger Frederick Johnson sold 31,227 shares of the company’s stock in a transaction dated Friday, April 26th. The shares were sold at an average price of $33.82, for a total value of $1,056,097.14. Following the transaction, the insider now owns 100,000 shares of the company’s stock, valued at $3,382,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Matthew Andrew Archambault sold 8,000 shares of the company’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $34.19, for a total transaction of $273,520.00. Following the completion of the transaction, the insider now directly owns 12,565 shares in the company, valued at approximately $429,597.35. The disclosure for this sale can be found here. In the last quarter, insiders have sold 81,520 shares of company stock valued at $2,750,739. 1.00% of the stock is currently owned by insiders.

Institutional Trading of Keurig Dr Pepper

Hedge funds have recently made changes to their positions in the business. Blue Trust Inc. lifted its position in shares of Keurig Dr Pepper by 312.1% during the second quarter. Blue Trust Inc. now owns 849 shares of the company’s stock worth $26,000 after purchasing an additional 643 shares in the last quarter. Turtle Creek Wealth Advisors LLC acquired a new stake in shares of Keurig Dr Pepper during the fourth quarter worth about $29,000. Riverview Trust Co acquired a new stake in shares of Keurig Dr Pepper during the second quarter worth about $39,000. GAMMA Investing LLC lifted its position in shares of Keurig Dr Pepper by 210.4% during the second quarter. GAMMA Investing LLC now owns 1,319 shares of the company’s stock worth $44,000 after purchasing an additional 894 shares in the last quarter. Finally, Mather Group LLC. acquired a new stake in shares of Keurig Dr Pepper during the first quarter worth about $45,000. Institutional investors and hedge funds own 85.23% of the company’s stock.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.